Akums Gets CDSCO Panel Nod to Study Cilnidipine, Telmisartan FDC film-coated tablet Dr. Divya Colin3 Oct 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Health Bulletin 27/September/2023 Isra Zaman27 Sept 2023 5:00 PM ISTHere are the top health stories for the day:NEET PG 2023: SC refuses to entertain plea challenging 'Zero' cutoff percentileObserving that the...
Ajanta Pharma Gets CDSCO panel conditional Nod to Manufacture, Market Cardiovascular FDC Drug Dr. Divya Colin20 Aug 2023 5:30 PM ISTNew Delhi: Citing that the proposed FDC is already approved in higher strength, the Subject Expert Committee (SEC) functional under the Central Drug...
Ajanta Pharma Launches World's 1st FDC Met XL AMT for Patients with Uncontrolled Hypertension and Cardiovascular Co-morbidity in India MD Brand Connect8 Aug 2023 11:53 AM ISTAjanta Pharma, one of the leaders in the cardiology segment has announced the launch of Met XL AMT, a novel triple drug combination for the...
Ajanta Pharma gets CDSCO Panel Nod to manufacture, market high blood pressure FDC drug Dr. Divya Colin28 May 2023 5:45 PM ISTNew Delhi: Ajanta Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
RSSDI releases guidelines for management of Hypertension in Diabetes Mellitus 2022 Dr. Nandita Mohan23 Dec 2022 12:15 PM ISTCatering to the pressing need to outline an evidence and experience-based comprehensive treatment yardstick, the first-ever Indian guideline for the...
RSSDI Releases Guidelines for Management of Hypertension in Diabetes Mellitus 2022 Dr. Kamal Kant Kohli21 Dec 2022 12:45 PM ISTCatering to the pressing need to outline an evidence and experience based comprehensive treatment yardstick, the first-ever Indian guideline for the...
Akum Pharma gets CDSCO panel nod to manufacture, market antihypertensive FDC drug Dr. Divya Colin27 Nov 2022 11:45 AM ISTNew Delhi: The Subject Expert Committee SEC, functional under the Central Drug Standard Control Organization CDSCO, has approved Akum Pharma to...
Does Telmisartan improve clinical outcomes in people with COVID-19? CLARITY Trial reports data on Indian Patients Meghna A Singhania22 Nov 2022 9:00 AM ISTNew Delhi: Can angiotensin receptor blockers disrupting the renin-angiotensin-system, help in improving COVID-19 outcomes?The answer seems to be 'no'...
Telmisartan fails to improve walking performance in lower extremity PAD patients: JAMA Aditi7 Oct 2022 10:30 AM ISTILLINOIS: A recent original investigation published in JAMA concluded the role of Telmisartan as "unsupportive" in improving the walking performance...
Dosing schedule and duration not defined: CDSCO panel tells Windlas Biotech on antihypertensive FDC Drug Dr. Divya Colin1 Oct 2022 5:00 PM ISTNew Delhi: Citing that dosing schedule and duration was not defined, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Batches of Glenmak TelmaAM categorized as spurious: CDSCO revises drug alert for May 2021 Dr. Divya Colin10 Sept 2022 6:00 PM ISTNew Delhi: After discovering a batch of Telma-AM as spurious, the Central Drugs Standard Control Organization (CDSCO), through a recently revised drug...
